Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID (IMAGE)

Vanderbilt University Medical Center

Vanderbilt Health to lead expanded multisite study of immunomodulation in long COVID

Caption

Members of the Vanderbilt Health team are evaluating the efficacy of the immunomodulatory drug baricitinib for treating the persistent neurological and cardiopulmonary symptoms of long COVID.

Credit

(photo by Donn Jones)

Usage Restrictions

Vanderbilt University Medical Center

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.